Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

8.21
+0.01000.12%
Post-market: 8.210.00000.00%16:41 EDT
Volume:751.10K
Turnover:6.19M
Market Cap:1.12B
PE:205.25
High:8.38
Open:8.21
Low:8.20
Close:8.20
Loading ...

Glass Lewis Recommends That Aurinia Shareholders Vote “for” All Proposals at 2025 Annual General Meeting

THOMSON REUTERS
·
30 Apr

BRIEF-ISS Recommends That Aurinia Shareholders Vote "For" All Proposals At 2025 Annual General Meeting

Reuters
·
29 Apr

Iss Recommends That Aurinia Shareholders Vote “for” All Proposals at 2025 Annual General Meeting

THOMSON REUTERS
·
29 Apr

ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting

Business Wire
·
29 Apr

Aurinia Pharmaceuticals Inc expected to post earnings of 10 cents a share - Earnings Preview

Reuters
·
28 Apr

BRIEF-Concerned Shareholders Of Aurinia Pharmaceuticals Announce Their Intention To Withhold Support For CEO Peter Greenleaf At 2025 Annual Meeting

Reuters
·
24 Apr

Mkt Capital and Lucien Selce: Believe Aurinia Shareholders Would Benefit From a Leaner, More Accountable Board

THOMSON REUTERS
·
24 Apr

High Growth Tech Stocks To Watch In The US Market

Simply Wall St.
·
08 Apr

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March

Insider Monkey
·
25 Mar

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?

Zacks
·
20 Mar

Aurinia Pharmaceuticals CMO Makes Significant Stock Sale

TIPRANKS
·
08 Mar

Signet Jewelers, Big Bear, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
08 Mar

Major Investment Alert: Kevin Tang Boosts Stake in Aurinia Pharmaceuticals

TIPRANKS
·
05 Mar

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock?

Zacks
·
05 Mar

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Simply Wall St.
·
02 Mar

Stock Track | Aurinia Pharmaceuticals Soars 5% as 2024 Earnings Beat Expectations

Stock Track
·
01 Mar

RBC Lowers Price Target on Aurinia Pharmaceuticals to $8 From $9, Keeps Outperform, Speculative Risk

MT Newswires Live
·
28 Feb

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
28 Feb

Aurinia Pharmaceuticals Inc (AUPH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
28 Feb

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals

TIPRANKS
·
28 Feb